Khan Najat
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Khan Najat. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| RXRX | Chief R&D Commercial Officer | Sale | 124,403 | $4.41 | $548,617 | Dec 22, 2025 |
| RXRX | Chief R&D Commercial Officer | Tax Withholding | 17,584 | $4.14 | $72,798 | Nov 17, 2025 |
| RXRX | Chief R&D Commercial Officer | Award / Grant | 84,925 | — | — | Nov 5, 2025 |
| RXRX | Chief R&D Commercial Officer | Sale | 36,599 | $5.52 | $202,026 | Aug 15, 2025 |
| RXRX | Chief R&D Commercial Officer | Tax Withholding | 3,796 | $4.25 | $16,133 | May 15, 2025 |
| RXRX | Chief R&D Commercial Officer | Award / Grant | 8,049 | — | — | Feb 3, 2025 |
| RXRX | Chief R&D Commercial Officer | Award / Grant | 496,972 | — | — | Aug 1, 2024 |